SLENYTO NEWS

The sleep burden survey

The sleep burden survey was done in cooperation Autism Speaks aiming at quantifying Insomnia burden in children with ASD and their families.

The results showed the great impact sleep problems in children with ASD have on child behavior and health, parents’ health and employment and the potential economic burden related to these findings.
The results were presented in 5 different abstracts at INSAR 2019, see the abstracts here:

1. Behavioral Concerns Associated with Sleep Disturbance Severity in Children with ASD
2. Association of Child and Adolescent Sleep Problems with Child and Parental Health
3. Sleep Problems in Children with ASD: Effects on Parental Employment
4. Sensitivity to Sounds and Touch and Sleep Concerns in Children with ASD
5. Measures of Effectiveness for Single-Question Sleep Problem Screeners in Children with ASD

 

  • Text size: A A A
  • Circadin
  • Recent news

    • Neurim Pharmaceuticals attends the ESCAP Congress in Vienna, Austria, 30 June – 2 July 2019
    • Slenyto (PedPRM) is now also available in Italy!
    • Neurim Pharmaceuticals attends the EPA Congress in Warsaw, Poland, April 7-9, 2019
  • Partners

    Partners